- Investing Ideas
- /
- U.S. High Growth Tech and AI Stocks
U.S. High Growth Tech and AI Stocks
Results
235
235 companies
MeiraGTx Holdings
Market Cap: US$534.6m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$6.16
7D
-20.9%
1Y
11.4%
Duos Technologies Group
Market Cap: US$47.4m
Designs, develops, deploys, and operates intelligent technology solutions in North America.
DUOT
US$5.22
7D
-15.1%
1Y
50.0%
RenovoRx
Market Cap: US$35.2m
A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$0.96
7D
-9.4%
1Y
-22.6%
Madrigal Pharmaceuticals
Market Cap: US$7.3b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$323.98
7D
-5.6%
1Y
32.5%
Nutanix
Market Cap: US$18.6b
Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.
NTNX
US$69.80
7D
-6.8%
1Y
14.2%
SideChannel
Market Cap: US$9.1m
SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.
SDCH
US$0.04
7D
1.3%
1Y
-46.5%
TeraWulf
Market Cap: US$1.0b
Operates as a digital asset technology company in the United States.
WULF
US$2.88
7D
-12.2%
1Y
23.6%
Checkpoint Therapeutics
Market Cap: US$197.3m
A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.04
7D
-0.5%
1Y
110.4%
Pagaya Technologies
Market Cap: US$789.1m
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial institutions and investors in the United States, Israel, the Cayman Islands, and internationally.
PGY
US$10.56
7D
-14.6%
1Y
11.4%
SpringWorks Therapeutics
Market Cap: US$3.3b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.
SWTX
US$41.88
7D
-11.3%
1Y
-9.5%
ACADIA Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$16.32
7D
-4.6%
1Y
-9.9%
Arcutis Biotherapeutics
Market Cap: US$1.9b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$15.64
7D
-9.5%
1Y
61.6%
CollPlant Biotechnologies
Market Cap: US$29.2m
A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
CLGN
US$2.58
7D
-16.8%
1Y
-51.0%
aTyr Pharma
Market Cap: US$268.4m
A biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States.
ATYR
US$2.88
7D
-17.5%
1Y
56.5%
Wix.com
Market Cap: US$9.1b
Operates a cloud-based web development platform for registered users and creators worldwide.
WIX
US$164.00
7D
-5.4%
1Y
19.2%
Kiniksa Pharmaceuticals International
Market Cap: US$1.6b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$21.77
7D
-6.1%
1Y
16.2%
Humacyte
Market Cap: US$264.5m
Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
HUMA
US$1.49
7D
-48.2%
1Y
-49.8%
MultiSensor AI Holdings
Market Cap: US$29.9m
Manufactures and distributes multi-sensor systems for thermographic and other use in various industrial applications in the United States and internationally.
MSAI
US$0.87
7D
-32.8%
1Y
-61.4%
Cellebrite DI
Market Cap: US$4.7b
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
CLBT
US$19.25
7D
-6.6%
1Y
77.7%
Precigen
Market Cap: US$438.1m
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$1.44
7D
-16.1%
1Y
3.2%
Citius Oncology
Market Cap: US$66.5m
Focuses on the development of novel targeted oncology therapies.
CTOR
US$0.86
7D
8.3%
1Y
-92.2%
HubSpot
Market Cap: US$29.8b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$582.02
7D
-7.2%
1Y
-4.6%
CrowdStrike Holdings
Market Cap: US$87.4b
Provides cybersecurity solutions in the United States and internationally.
CRWD
US$362.38
7D
-5.9%
1Y
13.4%
Atlassian
Market Cap: US$55.6b
Through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide.
TEAM
US$216.41
7D
-8.4%
1Y
10.4%
Sunshine Biopharma
Market Cap: US$4.0m
A pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.91
7D
-9.9%
1Y
-99.1%
XOMA Royalty
Market Cap: US$243.5m
Operates as a biotech royalty aggregator in the United States and the Asia Pacific.
XOMA
US$19.93
7D
-4.8%
1Y
-21.1%
Invivyd
Market Cap: US$72.0m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$0.61
7D
-16.4%
1Y
-85.8%
Market Cap: US$19.0b
Operates a digital community in the United States and internationally.
RDDT
US$110.05
7D
-12.3%
1Y
118.1%
Workiva
Market Cap: US$4.3b
Provides cloud-based reporting solutions in the Americas and internationally.
WK
US$76.06
7D
-12.3%
1Y
-6.5%
Neurocrine Biosciences
Market Cap: US$11.0b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$107.00
7D
-7.9%
1Y
-22.3%
Expensify
Market Cap: US$277.9m
Engages in the provision of a cloud-based expense management software platform in the United States and internationally.
EXFY
US$2.95
7D
-15.5%
1Y
89.1%
Zeta Global Holdings
Market Cap: US$3.2b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$14.03
7D
-10.8%
1Y
34.3%
Siyata Mobile
Market Cap: US$2.0m
Engages in the development and sale of cellular-based communications platform in the United States, Canada, Europe, Australia, the Middle East, and internationally.
SYTA
US$2.12
7D
5.0%
1Y
-99.7%
AppLovin
Market Cap: US$90.1b
Engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content in the United States and internationally.
APP
US$282.70
7D
-18.4%
1Y
305.5%
Rhythm Pharmaceuticals
Market Cap: US$3.5b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$52.97
7D
-1.4%
1Y
24.1%
Enfusion
Market Cap: US$1.4b
Provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
ENFN
US$11.15
7D
0.09%
1Y
20.7%